Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

CRME

Ls 2x Salesforc (CRME)

Ls 2x Salesforc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:CRME
일자시간출처헤드라인심볼기업
2023/04/2423:47UK RegulatoryLeverage Shares PLC Issuer Call Redemption ConfirmationLSE:CRMELs 2x Salesforc
2009/12/2207:05PR Newswire (US)Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase PlansLSE:CRME
2009/12/1808:00PR Newswire (US)Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator StudyLSE:CRME
2009/11/0922:40PR Newswire (US)Cardiome Reports Third Quarter ResultsLSE:CRME
2009/11/0708:00PR Newswire (US)Cardiome to Release Third Quarter ResultsLSE:CRME
2009/11/0304:35PR Newswire (US)Cardiome To Present At Oppenheimer Healthcare ConferenceLSE:CRME
2009/10/2905:58PR Newswire (US)Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 TrialLSE:CRME
2009/10/1709:54PR Newswire (US)Cardiome Pharma Corp. Announces Final Results of Tender OfferLSE:CRME
2009/10/1419:00PR Newswire (US)Cardiome Pharma Corp. Announces Preliminary Results of Tender OfferLSE:CRME
2009/09/0203:57PR Newswire (US)Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender OfferLSE:CRME
2009/08/2902:30PR Newswire (US)Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of LSE:CRME
2009/08/2606:11PR Newswire (US)Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common SharesLSE:CRME
2009/08/1120:45PR Newswire (US)Cardiome Reports Second Quarter ResultsLSE:CRME
2009/08/1108:45PR Newswire (US)Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol AgreementLSE:CRME
2009/08/1105:35PR Newswire (US)Cardiome to Hold Conference CallLSE:CRME
2009/08/0406:16PR Newswire (US)Cardiome Announces Management TransitionLSE:CRME
2009/07/2900:45PR Newswire (US)Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.LSE:CRME
2009/05/1921:30PR Newswire (US)Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now EffectiveLSE:CRME
2009/05/1605:05PR Newswire (US)Cardiome Reports First Quarter ResultsLSE:CRME
2009/04/0907:13PR Newswire (US)Cardiome to Hold Conference CallLSE:CRME
2008/11/2907:31PR Newswire (US)Cardiome Discloses Chairman And CEO's Involuntary Share SaleLSE:CRME
2008/11/1508:40PR Newswire (US)Cardiome Reports Third Quarter ResultsLSE:CRME
2008/10/2411:40PR Newswire (US)Cardiome Announces Filing Of Shelf Registration StatementLSE:CRME
2008/10/1001:20PR Newswire (US)Cardiome Provides Regulatory UpdateLSE:CRME
2008/08/1305:05PR Newswire (US)Cardiome Reports Second Quarter ResultsLSE:CRME
2008/08/1205:30PR Newswire (US)Cardiome to Release Second Quarter Results and Hold Conference CallLSE:CRME
2008/08/1122:18PR Newswire (US)Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)LSE:CRME
2008/07/2403:10PR Newswire (US)Cardiome Announces Preferred Share FinancingLSE:CRME
2008/07/1421:25PR Newswire (US)Cardiome Announces Positive Phase 2b Results For Oral VernakalantLSE:CRME
2008/07/1401:00PR Newswire (US)Cardiome To Hold Conference CallLSE:CRME
 검색 관련기사 보기:LSE:CRME